|
Screening of FDA-Approved Drugs Using a 384-WellPlate-Based Biofilm Platform: The Case of Fingolimod
|
31 December 2020 |
|
Combined Effect of Naturally-Derived Biofilm Inhibitors and Differentiated HL-60 Cells in the Prevention of Staphylococcus aureus Biofilm Formation
|
13 November 2020 |
|
Non-leaching, Highly Biocompatible Nanocellulose Surfaces That Efficiently Resist Fouling by Bacteria in an Artificial Dermis Model
|
29 October 2020 |
|
3D-Printed Drug Delivery Systems: The Effects of Drug Incorporation Methods on Their Release and Antibacterial Efficiency
|
28 September 2020 |
|
Production of Drug Delivery Systems Using Fused Filament Fabrication: A Systematic Review
|
28 September 2020 |
|
Optimization of a High-Throughput 384-Well Plate-Based Screening Platform with Staphylococcus aureus ATCC 25923 and Pseudomonas aeruginosa ATCC 15442 Biofilms
|
28 September 2020 |
|
Minimum information guideline for spectrophotometric and fluorometric methods to assess biofilm formation in microplates
|
22 September 2020 |
|
Strategies to Prevent Biofilm Infections on Biomaterials: Effect of Novel Naturally-Derived Biofilm Inhibitors on a Competitive Colonization Model of Titanium by Staphylococcus aureus and SaOS-2 Cells
|
22 September 2020 |
|
PRINT-AID project featured in Mediuutiset
|
06 February 2018 |
|
PRINT-AID publications to appear soon
|
03 February 2017 |
